2796210-93-8
2796210-93-8
Chemical Structure
TLR8 agonist 10
- CAS No.: 2796210-93-8
- Formula:C20H30N4
- Molecular Weight:326.48
InChIKey: WCMVGCOXCZBBRL-UHFFFAOYSA-N
SMILES: CCCCNC1=CC(CC2=CC=C(C=C2)CN(C)C)=C(N=C1N)C
Biological Activity: TLR8 agonist 10 is a selective TLR8 agonist with an EC50 of 0.019 μM in humans. TLR8 agonist 10 activates TLR8-mediated signaling pathways. As a latency-reversing agent, TLR8 agonist 10 reactivates latent HIV-1 reservoirs. TLR8 agonist 10 activates innate cytotoxic natural killer cells to target HIV-infected CD4+ T cells. TLR8 agonist 10 is applicable to research related to HIV-1 infection[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
TLR8 agonist 10 | TLR8 agonist 10 is a selective TLR8 agonist with an EC50 of 0.019 μM in humans. TLR8 agonist 10 activates TLR8-mediated signaling pathways. As a latency-reversing agent, TLR8 agonist 10 reactivates latent HIV-1 reservoirs. TLR8 agonist 10 activates innate cytotoxic natural killer cells to target HIV-infected CD4+ T cells. TLR8 agonist 10 is applicable to research related to HIV-1 infection. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
